BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31589995)

  • 21. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
    Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
    Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study.
    Littooij AS; Kwee TC; de Keizer B; Bruin MC; Coma A; Beek FJ; Fijnheer R; Nievelstein RA
    J Magn Reson Imaging; 2015 Dec; 42(6):1646-55. PubMed ID: 25952024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very early indicators of response to systemic therapy in lymphoma patients based on alterations in water diffusivity--a preliminary experience in 20 patients undergoing whole-body diffusion-weighted imaging.
    Horger M; Claussen C; Kramer U; Fenchel M; Lichy M; Kaufmann S
    Eur J Radiol; 2014 Sep; 83(9):1655-64. PubMed ID: 24972451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
    Berardo S; Sukhovei L; Andorno S; Carriero A; Stecco A
    Radiol Med; 2021 Mar; 126(3):445-452. PubMed ID: 32812173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
    Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
    J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME
    Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma.
    Zhang B; Bian B; Zhao Z; Lin F; Zhu Z; Lou M
    BMC Med Imaging; 2021 Jun; 21(1):98. PubMed ID: 34103001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A; Araki Y; Tanaka Y; Otsuki S; Yamada A; Moriyama M; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Furuya N; Fujimoto H; Okabe S; Gotoh M; Suzuki K; Saito K; Gotoh A
    PLoS One; 2021; 16(7):e0253025. PubMed ID: 34242226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI.
    Winfield JM; Poillucci G; Blackledge MD; Collins DJ; Shah V; Tunariu N; Kaiser MF; Messiou C
    Eur Radiol; 2018 Apr; 28(4):1687-1691. PubMed ID: 29134357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
    Ryoo I; Kim JH; Choi SH; Sohn CH; Kim SC
    Magn Reson Med Sci; 2015; 14(4):337-45. PubMed ID: 26104081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
    Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
    Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of whole-body diffusion weighted imaging (WB-DWI) in the diagnosis and monitoring of newly diagnosed multiple myeloma].
    Wang PF; Li YC; Xu Y; Wang XM; Guo L; Fu CC
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):129-133. PubMed ID: 28279037
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
    Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
    Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-body low-dose CT recognizes two distinct patterns of lytic lesions in multiple myeloma patients with different disease metabolism at PET/MRI.
    Zambello R; Crimì F; Lico A; Barilà G; Branca A; Guolo A; Varin C; Vezzaro R; Checuz L; Scapin V; Berno T; Pizzi M; Ponzoni A; De Biasi E; Vio S; Semenzato G; Zucchetta P; Lacognata C
    Ann Hematol; 2019 Mar; 98(3):679-689. PubMed ID: 30539276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different MRI sequences in lesion detection and early response evaluation of diffuse large B-cell lymphoma--a whole-body MRI and diffusion-weighted imaging study.
    Wu X; Nerisho S; Dastidar P; Ryymin P; Järvenpää R; Pertovaara H; Eskola H; Kellokumpu-Lehtinen PL
    NMR Biomed; 2013 Sep; 26(9):1186-94. PubMed ID: 23483722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-Body Diffusion Imaging Applying Simultaneous Multi-Slice Excitation.
    Kenkel D; Wurnig MC; Filli L; Ulbrich EJ; Runge VM; Beck T; Boss A
    Rofo; 2016 Apr; 188(4):381-8. PubMed ID: 26815283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apparent diffusion coefficient measurements of bone marrow infiltration patterns in multiple myeloma for the assessment of tumor burden - a feasibility study.
    Xiong X; Ma Y; Dai Y; Hu C; Zhang Y
    Radiol Oncol; 2023 Dec; 57(4):455-464. PubMed ID: 38038425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.
    Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP
    AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.
    Ji X; Huang W; Dong H; Shen Z; Zheng M; Zou D; Shen W; Xia S
    Quant Imaging Med Surg; 2021 Feb; 11(2):641-651. PubMed ID: 33532264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of diffusion-weighted MR imaging with ADC measurement for distinguishing between the histopathological types of sinonasal neoplasms.
    Gencturk M; Ozturk K; Caicedo-Granados E; Li F; Cayci Z
    Clin Imaging; 2019; 55():76-82. PubMed ID: 30769222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.